These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4563178

  • 1. [Mode of action of oral hypoglycemic sulfonylureas].
    Paes E.
    Rev Iber Endocrinol; 1972; 19(113):449-59. PubMed ID: 4563178
    [No Abstract] [Full Text] [Related]

  • 2. [The present status of the question of the mechanism of action of sulfanilamide hypoglycemic preparations and several aspects of their use in the treatment of diabetes mellitus].
    Mordkovskaia NM.
    Probl Endokrinol (Mosk); 1971; 17(5):121-5. PubMed ID: 4337075
    [No Abstract] [Full Text] [Related]

  • 3. Glibenclamide: a review.
    Drugs; 1971; 1(2):116-40. PubMed ID: 5004340
    [No Abstract] [Full Text] [Related]

  • 4. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV, Gladkikh AI.
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract] [Full Text] [Related]

  • 5. Oral antidiabetic therapy.
    Melander A, Almér LO, Sartor G, Scherstén B, Wåhlin-Boll E.
    Acta Med Scand Suppl; 1981; 656():55-7. PubMed ID: 7046351
    [No Abstract] [Full Text] [Related]

  • 6. [Molecular mechanism of action of sulfonylureas].
    Ammon HP.
    Dtsch Med Wochenschr; 1988 May 27; 113(21):864-70. PubMed ID: 3286184
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A, Ribes G, Mariani MM, Alric R.
    Acta Diabetol Lat; 1973 May 27; 10(2):261-82. PubMed ID: 4200420
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.
    Beck-Nielsen H, Hother-Nielsen O, Pedersen O.
    Diabet Med; 1988 Oct 27; 5(7):613-20. PubMed ID: 2975544
    [No Abstract] [Full Text] [Related]

  • 9. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A.
    Drugs; 1971 Oct 27; 1(2):109-15. PubMed ID: 4999930
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of insulin secretion and its modulation by sulfonylureas.
    Panten U.
    Contrib Nephrol; 1989 Oct 27; 73():16-21; discussion 22-3. PubMed ID: 2689091
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A, Mariani MM, Ribes G, Alric R.
    Acta Diabetol Lat; 1973 Oct 27; 10(2):261-82. PubMed ID: 4200675
    [No Abstract] [Full Text] [Related]

  • 12. Blockade of insulin secretion by mannoheptulose.
    Simon E, Frenkel G, Kraicer PF.
    Isr J Med Sci; 1972 Jun 27; 8(6):743-52. PubMed ID: 4626312
    [No Abstract] [Full Text] [Related]

  • 13. Effect of sulfonylureas on calcium uptake and insulin secretion by islets of Langerhans.
    Malaisse WJ, Mahy M, Malaisse-Lagae F.
    Arch Int Pharmacodyn Ther; 1971 Jul 27; 192(1):205-7. PubMed ID: 4937349
    [No Abstract] [Full Text] [Related]

  • 14. Oral hypoglycemic agents.
    Boyden T, Bressler R.
    Adv Intern Med; 1979 Jul 27; 24():53-70. PubMed ID: 371368
    [No Abstract] [Full Text] [Related]

  • 15. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb 27; 40(2):227-33. PubMed ID: 190857
    [Abstract] [Full Text] [Related]

  • 16. [Extrapancreatic effects of oral sulfonylureas].
    Beyer J, Cordes U, Krall H, Rosak C, Schöffling K.
    Verh Dtsch Ges Inn Med; 1971 Feb 27; 77():539-43. PubMed ID: 5155894
    [No Abstract] [Full Text] [Related]

  • 17. Glypentide: a new hypoglycaemic agent.
    Morell J.
    Biochem Pharmacol; 1974 Oct 15; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract] [Full Text] [Related]

  • 18. The mechanism of sulfonylurea stimulation of insulin release.
    Hellman B.
    Acta Biol Med Ger; 1982 Oct 15; 41(12):1211-9. PubMed ID: 6765162
    [Abstract] [Full Text] [Related]

  • 19. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
    Loubatières AL, Ribes G, Loubatières-Mariani MM.
    C R Seances Soc Biol Fil; 1972 Oct 15; 166(8):1047-50. PubMed ID: 4573746
    [No Abstract] [Full Text] [Related]

  • 20. [The blood-sugar depressing and betacytotrope effect of glibornurid in healthy and in gastric-resected persons (author's transl)].
    Grabner W, Matzkies F, Randerbrock V, Berg G.
    Med Klin; 1973 Aug 24; 68(34):1101-5. PubMed ID: 4598149
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.